Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow: Index Slips to 24,220.10, Outlook for Tuesday 16 June 2026

  • June 15, 2026
  • Posted by: Ankit Jaiswal
  • Category: Market
No Comments
Nifty Pharma Prediction for Tomorrow

Nifty Pharma prediction for tomorrow, 16 June 2026: closed 24,220.10 (-0.66%). Pivot 24,324, resistance 24,450, support 24,094. Tuesday is Nifty weekly expiry. VIX 14.35.

The nifty pharma prediction for tomorrow, Tuesday 16 June 2026, sees Nifty Pharma consolidate after closing at 24,220.10, down 0.66 percent today. Pharma offers defensive growth via specialty pipelines, with rupee strength and US pricing as margin risks.

Ankit Jaiswal, Senior Research Analyst at Univest, breaks down the nifty pharma prediction for tomorrow with the levels that matter, the constituent moves and the events that decide Tuesday, which is also the Nifty weekly options expiry.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • How Monday Set Up the Nifty Pharma Prediction for Tomorrow
  • Key Levels for the Nifty Pharma Prediction for Tomorrow
  • Constituents That Moved Today
  • What Will Drive the Nifty Pharma Prediction for Tomorrow
  • Trading Strategy for Tomorrow
  • Nifty Pharma Prediction for Tomorrow: Quick Answers
  • Conclusion
  • FAQs on the Nifty Pharma Prediction for Tomorrow
    • What is the nifty pharma prediction for tomorrow, 16 June 2026?
    • What are the key levels for Nifty Pharma tomorrow?
    • What will drive Nifty Pharma tomorrow?
    • Which stocks moved the Nifty Pharma pack today?
    • Who provides the Univest view on the nifty pharma prediction for tomorrow?

How Monday Set Up the Nifty Pharma Prediction for Tomorrow

The index moved down 0.66 percent today to 24,220.10, in a session where the broader market gapped up and then faded from its highs. Pharma eased as the rupee and US pricing concerns weighed. That backdrop frames the nifty pharma prediction for tomorrow.

Key Levels for the Nifty Pharma Prediction for Tomorrow

Level Value
Today’s close 24,220.10 (-0.66%)
Day range 24,198.15 to 24,553.50
Pivot (Tue) 24,324
Resistance R1 / R2 24,450 / 24,679
Support S1 / S2 24,094 / 23,969
India VIX 14.35

3 Stocks Building Serious Momentum Right Now

When Univest analysts identify high-conviction stock opportunities, investors pay attention.

Our research team has now shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.

  • Discover stocks investors are actively accumulating
  • High-conviction opportunities backed by research
  • Designed for the next phase of market growth

Unlock the latest Top Stock Picks on Univest

See the Stocks →

The pivot for Tuesday sits at 24,324, with resistance at 24,450 and 24,679 and support at 24,094 and 23,969. These levels anchor the nifty pharma prediction for tomorrow.

Constituents That Moved Today

Stock LTP (Rs) Change
Sun Pharma 1,795.00 -0.70%
Cipla 1,382.00 -0.53%
Dr Reddys 1,270.00 -0.42%

Sun Pharma leads the watch list, and the spread above is what traders track for the nifty pharma prediction for tomorrow into the expiry session.

What Will Drive the Nifty Pharma Prediction for Tomorrow

  • Sector trigger: Pharma offers defensive growth via specialty pipelines, with rupee strength and US pricing as margin risks.
  • Nifty weekly expiry: Tuesday 16 June is the Nifty weekly options expiry, which typically lifts intraday volatility and pins prices toward heavily written strikes
  • Fed on Wednesday night: The US Fed statement lands late Wednesday night India time, the first under new Chair Kevin Warsh, so Tuesday is a positioning session ahead of the event
  • Today’s reversal: The market gapped up and printed fresh highs before fading into the close, leaving upper wicks on the daily candles, a caution flag for tomorrow
  • Volatility: India VIX cooled to 14.35, the calmest reading in over a week, signalling traders are not pricing large two-way risk into the expiry

Track All Nifty Pharma Stocks Live on the Univest Screener

Trading Strategy for Tomorrow

The nifty pharma prediction for tomorrow favours a disciplined, level-based approach on an expiry day.

  • Watch the pivot: Holding above 24,324 keeps the bias positive, a slip below shifts it to the 24,094 support
  • Trade the expiry carefully: Weekly expiry whips both ways, smaller size and defined stops beat directional conviction
  • Resistance to clear: 24,450 is the first ceiling, a sustained move above it opens 24,679
  • Stay light before the Fed: Wednesday night brings the Fed statement, so avoid carrying oversized overnight risk from Tuesday

Nifty Pharma Prediction for Tomorrow: Quick Answers

Nifty Pharma outlook for tomorrow: Cautious with a pivot at 24,324, resistance 24,450, support 24,094.

Key resistance and support: Resistance 24,450 and 24,679, support 24,094 and 23,969.

The big event: The Nifty weekly expiry on Tuesday and the US Fed statement late Wednesday night India time.

Download the Univest iOS App or Univest Android App to track the nifty pharma prediction for tomorrow with live levels and daily research from Univest analysts.

Conclusion

The nifty pharma prediction for tomorrow, 16 June 2026, is for a cautious session. With the index closing at 24,220.10, the pivot at 24,324 is the line to watch, resistance sits at 24,450 and support at 24,094, with the Nifty weekly expiry and the Fed shaping the path. Univest analysts will refresh the nifty pharma prediction for tomorrow as the session unfolds. Check back for the next update.

Disclaimer: Data and figures in this article are sourced from publicly available information and live market feeds as of the close of trade on 15 June 2026. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty Pharma Prediction for Tomorrow

What is the nifty pharma prediction for tomorrow, 16 June 2026?

Ans. The nifty pharma prediction for tomorrow is for a cautious session. The index closed at 24,220.10 -0.66 percent today, with the Tuesday pivot at 24,324, resistance at 24,450 and support at 24,094, ahead of the Nifty weekly options expiry.

What are the key levels for Nifty Pharma tomorrow?

Ans. The Tuesday pivot is 24,324. Resistance sits at 24,450 and 24,679, while support is at 24,094 and 23,969. Today’s range was 24,198.15 to 24,553.50.

What will drive Nifty Pharma tomorrow?

Ans. Pharma offers defensive growth via specialty pipelines, with rupee strength and US pricing as margin risks. Alongside that, the Nifty weekly expiry on Tuesday and the build-up to Wednesday night’s US Fed statement under new Chair Kevin Warsh set the broader frame for the nifty pharma prediction for tomorrow.

Which stocks moved the Nifty Pharma pack today?

Ans. Sun Pharma leads the watch list, with Cipla, Dr Reddys also in focus for the nifty pharma prediction for tomorrow.

Who provides the Univest view on the nifty pharma prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest provides the view, with Univest analysts tracking the index levels, constituent moves and the expiry through the session.



Prediction for tomorrow
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply